Latest Breaking News On - Robertm brenner - Page 1 : comparemela.com

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results

Vera Therapeutics Provides Business Update and Reports First Quarter 2024 Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Robertm brennerJoyce allaireMari purpuraMarshall fordyceWilliamd turnerAmplyx pharmaceuticals incPfizer incEuropean renal association congressExchange commissionVera therapeutics incRecent business highlightsChief medical officerChief developmentQuarter ended marchB cell activating factorInducing ligand

Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K

Vera Therapeutics : Provides Business Update and Reports First Quarter 2024 Financial Results - Form 8-K
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

Marshall fordyceWilliamd turnerMari purpuraJoyce allaireRobertm brennerAmplyx pharmaceuticals incPfizer incVera therapeutics incEuropean renal association congressExchange commissionVera therapeutics provides business updateReports first quarterRecent business highlightsChief medical officerChief development officerQuarter ended march

Vera Therapeutics, Inc Announces Executive Changes

Vera Therapeutics, Inc. announced the appointments of two industry veterans to help lead the development of the company?s drug programs including its late-stage product candidate, atacicept, to treat.

United statesStanford universityWilliamd turnerRobertm brennerOrionis biosciencesCelia linAlbert einstein college of medicineVera therapeutics incRegulatory affairsCalifornia state university at long beachSierra oncology incJohns hopkins universityStanford university medical centerGlobal quality at dynavax technologies corporationVera therapeuticsChief medical officer

Vera Therapeutics Announces Appointment of Industry

BRISBANE, Calif., Jan. 08, 2024 (GLOBE NEWSWIRE) Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company developing and.

Stanford universityUnited statesJoyce allaireOrionis biosciencesCelia linMarshall fordyceWilliamd turnerMari purpuraRobertm brennerJohns hopkins universityGlobal quality at dynavax technologies corporationVera therapeutics incCalifornia state university at long beachAlbert einstein college of medicineRegulatory affairsSierra oncology inc